NEOGEN Q3 FY26 Guidance vs Delivery (NEOGEN Management Mirror)

Did NEOGEN's management deliver what it guided? Guidance vs actual performance and tone changes across recent earnings calls, as of the Q3 FY26 (Dec-2025 Qtr) concall.

  • NEOGEN Financials
  • NEOGEN Shareholding Pattern
  • NEOGEN Earnings Documents
  • NEOGEN Announcements
  • NEOGEN Corporate Actions
  • NEOGEN Bulk, Block & Insider Deals
  • NEOGEN Delivery Data
  • NEOGEN Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Neogen Chemicals Ltd (NEOGEN) Q3FY26 Management Mirror - Dec-2025 Qtr

Revenue & Financial Outlook

Reaffirmed base business guidance in Dec'25 Qtr, expecting double-digit growth in FY27/FY28. This follows a steady outlook from Sep'25 Qtr (INR 950-1,000 crore target for FY27) and Jun'25 Qtr (INR 825-875 crore target for FY26).

Maintained FY27 battery chemicals revenue guidance of INR 400-500 crore in Dec'25 Qtr, consistent with the outlook established in Sep'25 Qtr after being adjusted downward from earlier expectations.

Lowered near-term battery chemicals revenue guidance significantly in Sep'25 Qtr to INR 30-40 crore (FY26) due to delayed demand, down from the ~INR 300 crore run-rate anticipated in Jun'25 Qtr.

4 more themes on the ELITE plan.

  • NEOGEN Q3FY26 Concall Summary
  • NEOGEN Q3FY26 Concall Transcript
  • NEOGEN Q2FY26 Management Mirror (Sep-2025 Qtr)
  • NEOGEN Q4FY26 Management Mirror (Mar-2026 Qtr)